223 related articles for article (PubMed ID: 24114144)
1. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
2. CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties.
Tam JW; Kullas AL; Mena P; Bliska JB; van der Velden AW
Infect Immun; 2014 Jun; 82(6):2606-14. PubMed ID: 24711563
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
4. Distinct Role of CD11b
Wu SY; Chiang CS
Cells; 2019 Dec; 9(1):. PubMed ID: 31878276
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
6. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
[TBL] [Abstract][Full Text] [Related]
7. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
[TBL] [Abstract][Full Text] [Related]
8. CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden.
Källberg E; Stenström M; Liberg D; Ivars F; Leanderson T
BMC Immunol; 2012 Dec; 13():69. PubMed ID: 23234398
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Ly6G
Heim CE; West SC; Ali H; Kielian T
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249747
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.
Sceneay J; Chow MT; Chen A; Halse HM; Wong CS; Andrews DM; Sloan EK; Parker BS; Bowtell DD; Smyth MJ; Möller A
Cancer Res; 2012 Aug; 72(16):3906-11. PubMed ID: 22751463
[TBL] [Abstract][Full Text] [Related]
12. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
Wu F; Dang D; Guo J; Li H; Yang K; Zhao D; Guo P; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):789-92, 797. PubMed ID: 25108427
[TBL] [Abstract][Full Text] [Related]
13. Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b
Shime H; Matsumoto M; Seya T
Cell Death Differ; 2017 Mar; 24(3):385-396. PubMed ID: 27834952
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth.
Deronic A; Tahvili S; Leanderson T; Ivars F
BMC Cancer; 2016 Jul; 16():440. PubMed ID: 27400708
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
[TBL] [Abstract][Full Text] [Related]
16. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
17. Expansion of CD11b
Perfilyeva YV; Abdolla N; Ostapchuk YO; Tleulieva R; Krasnoshtanov VC; Belyaev NN
Inflamm Res; 2017 Aug; 66(8):711-724. PubMed ID: 28455608
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of B220
Zhang Z; Huang X; Wang E; Huang Y; Yang R
Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
[TBL] [Abstract][Full Text] [Related]
19. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.
Chow MT; Sceneay J; Paget C; Wong CS; Duret H; Tschopp J; Möller A; Smyth MJ
Cancer Res; 2012 Nov; 72(22):5721-32. PubMed ID: 22986739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
